WILLIAM WARREN: Open Payments
NPI 1487915716 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$718 in 32 payments from 11 companies in 2025. Trend: 2023 $1,110 · 2024 $1,029 · 2025 $718
Food & beverage: $718
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $268 |
| Janssen Biotech, Inc. | 5 | $120 |
| Ipsen Biopharmaceuticals, Inc | 2 | $61 |
| QOL Medical, LLC | 2 | $55 |
| Ardelyx, Inc. | 3 | $53 |
| Aimmune Therapeutics, Inc. | 1 | $35 |
| PFIZER INC. | 2 | $31 |
| GENZYME CORPORATION | 1 | $30 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Lilly USA, LLC | 1 | $22 |
Products named: TREMFYA, LINZESS, SKYRIZI, RINVOQ, IQIRVO, Sucraid, IBSRELA, VOWST.
Industry payments across VA — which companies pay providers there.
